Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

CytomX Therapeutics Inc

CTMX
Current price
0.74 USD -0.013 USD (-1.76%)
Last closed 0.43 USD
ISIN US23284F1057
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 52 545 540 USD
Yield for 12 month -56.18 %
1Y
3Y
5Y
10Y
15Y
CTMX
21.11.2021 - 28.11.2021

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the validation of targets for antibody-drug conjugates (ADCs), opening therapeutic window for novel T-cell engagers (TCEs) targeting solid tumors, and increasing the therapeutic index for immune modulators, such as cytokines; and PROBODY platform in preclinical research in areas outside of oncology. It also develops CX-904, a T-cell-engaging bispecific antibody targeting the epidermal growth factor receptor (EGFR) on tumor cells and the CD3 receptor on T cells; CX-2051, a conditionally activated ADC for optimizing the therapeutic index for EpCAM-expressing epithelial cancers, including colorectal cancer; and CX-801, an interferon alpha-2b PROBODY cytokine. In addition, the company's development pipeline comprises CX-2029, a conditional activated ADC targeting CD71; and BMS-986288, a PROBODY version of non-fucosylated ipilimumab. It has strategic collaborations with Amgen, Astellas, Bristol Myers Squibb, Regeneron, and Moderna; and clinical trial collaboration and supply agreement with Merck for the evaluation of CX-801 in combination with anti-PD-1 therapy, KEYTRUDA (pembrolizumab). The company was founded in 2008 and is based in South San Francisco, California. Address: 151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.75 USD

P/E ratio

1.64

Dividend Yield

Current Year

+138 103 000 USD

Last Year

+101 214 000 USD

Current Quarter

+38 093 000 USD

Last Quarter

+33 432 000 USD

Current Year

+138 103 000 USD

Last Year

+101 214 000 USD

Current Quarter

+38 093 000 USD

Last Quarter

+33 432 000 USD

Key Figures CTMX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 26 763 000 USD
Operating Margin TTM 46.41 %
Price to Earnings 1.64
Return On Assets TTM 9.69 %
PEG Ratio -1.80
Return On Equity TTM -5 475.03 %
Wall Street Target Price 4.75 USD
Revenue TTM 138 103 008 USD
Book Value -0.0060 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 43.20 %
Dividend Yield
Gross Profit TTM 138 103 008 USD
Earnings per share 0.40 USD
Diluted Eps TTM 0.40 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY 2 515.80 %
Profit Margin 23.08 %

Dividend Analytics CTMX

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History CTMX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation CTMX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 1.64
Forward PE 0.87
Enterprise Value Revenue 0.016
Price Sales TTM 0.38
Enterprise Value EBITDA 3.86
Price Book MRQ 5.04

Financials CTMX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CTMX

For 52 weeks

0.40 USD 5.85 USD
50 Day MA 0.66 USD
Shares Short Prior Month 9 004 795
200 Day MA 1.01 USD
Short Ratio 2.67
Shares Short 9 355 778
Short Percent 11.76 %